Literature DB >> 16219618

National Institutes of Health State-of-the-Science Conference statement. Improving End-of-Life Care. December 6-8, 2004.

.   

Abstract

The draft conference statement is presented in its entirety. This report addresses five important questions, i.e. What defines the transition to end of life; What outcome variables are important indicators of the quality of the end-of-life experience for the dying person and for the surviving loved ones; What patient, family, and health care system factors are associated with improved or worsened outcomes; What processes and interventions are associated with improved or worsened outcomes; What are the future research directions for improving end-of-life care? The report includes conclusions, a list of panel members, speakers, the planning committee and conference sponsors.

Entities:  

Mesh:

Year:  2005        PMID: 16219618

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  4 in total

1.  Advanced dementia research in the nursing home: the CASCADE study.

Authors:  Susan L Mitchell; Dan K Kiely; Richard N Jones; Holly Prigerson; Ladislav Volicer; Joan M Teno
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jul-Sep       Impact factor: 2.703

2.  Hospice use and outcomes in nursing home residents with advanced dementia.

Authors:  Dan K Kiely; Jane L Givens; Michele L Shaffer; Joan M Teno; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2010-12       Impact factor: 5.562

3.  Expectations and outcomes of prolonged mechanical ventilation.

Authors:  Christopher E Cox; Tereza Martinu; Shailaja J Sathy; Alison S Clay; Jessica Chia; Alice L Gray; Maren K Olsen; Joseph A Govert; Shannon S Carson; James A Tulsky
Journal:  Crit Care Med       Date:  2009-11       Impact factor: 7.598

4.  Challenges and strategies in the administration of a population based mortality follow-back survey design.

Authors:  Beverley Lawson; Kristine Van Aarsen; Frederick Burge
Journal:  BMC Palliat Care       Date:  2013-08-06       Impact factor: 3.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.